Loading...
Amedisys, Inc.
AMED•NASDAQ
Healthcare
Medical - Care Facilities
$97.94
$0.11(0.11%)
Amedisys, Inc. (AMED) Financial Performance & Income Statement Overview
Review Amedisys, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.005%
↑ 5.005%
Operating Income Growth
-39.55%
↓ 39.55%
Net Income Growth
543.53%
↑ 543.53%
Operating Cash Flow Growth
61.58%
↑ 61.58%
Operating Margin
4.98%
↑ 4.98%
Gross Margin
37.73%
↑ 37.73%
Net Profit Margin
4.82%
↑ 4.82%
ROE
9.93%
↑ 9.93%
ROIC
6.98%
↑ 6.98%
Amedisys, Inc. (AMED) Income Statement & Financial Overview
Review Amedisys, Inc.'s (AMED) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $594.78M | $598.05M | $587.67M | $591.19M |
| Cost of Revenue | $334.05M | $344.61M | $337.56M | $460.64M |
| Gross Profit | $260.73M | $253.44M | $250.11M | $130.54M |
| Gross Profit Ratio | $0.44 | $0.42 | $0.43 | $0.22 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $196.16M | $202.70M | $198.34M | $195.75M |
| Operating Expenses | $217.37M | $273.06M | $219.78M | $66.43M |
| Total Costs & Expenses | $683.39M | $617.68M | $557.34M | $527.07M |
| Interest Income | $2.87M | $2.75M | $2.02M | $1.62M |
| Interest Expense | $6.42M | $6.98M | $7.77M | $7.89M |
| Depreciation & Amortization | $4.45M | $15.41M | $4.77M | $6.36M |
| EBITDA | $89.23M | $3.16M | $25.99M | $70.47M |
| EBITDA Ratio | $0.15 | $0.005 | $0.04 | $0.12 |
| Operating Income | $43.36M | -$19.62M | $30.33M | $64.11M |
| Operating Income Ratio | $0.07 | -$0.03 | $0.05 | $0.11 |
| Other Income/Expenses (Net) | $47.85M | $396000.00 | -$1.34M | -$2.98M |
| Income Before Tax | $91.20M | -$19.23M | $28.99M | $49.23M |
| Income Before Tax Ratio | $0.15 | -$0.03 | $0.05 | $0.08 |
| Income Tax Expense | $29.38M | $6.29M | -$12.47M | $16.66M |
| Net Income | $61.01M | -$20.38M | $41.46M | $32.30M |
| Net Income Ratio | $0.10 | -$0.03 | $0.07 | $0.05 |
| EPS | $1.86 | -$0.62 | $1.27 | $0.99 |
| Diluted EPS | $1.84 | -$0.62 | $1.25 | $0.98 |
| Weighted Avg Shares Outstanding | $32.79M | $32.72M | $32.74M | $32.71M |
| Weighted Avg Shares Outstanding (Diluted) | $33.22M | $32.72M | $33.13M | $33.05M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan